Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Talniflumate is a prodrug form of the COX-2 inhibitor niflumic acid (Item No. 70650).1 It decreases the rate of chloride/bicarbonate exchange by 55% in isolated mouse intestinal villous epithelial cells when used at a concentration of 100 µM.2 Dietary administration of talniflumate (88 mg/kg per day) increases survival but has no effect on the number of crypt goblet cells in the jejunum or cecum in a cystic fibrosis mouse model of distal intestinal obstructive syndrome.
WARNING This product is not for human or veterinary use.
1. Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography. Biomed. Chromatogr. 19(1), 32-35 (2005).
2. Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. J. Pharmacol. Exp. Ther. 317(1), 275-283 (2006).